[Molecular imaging in oncology using targeted ultrasound contrast agents]. / Molekulare Bildgebung in der Onkologie: Tumor-spezifische Ultraschallkontrastmittel.
Praxis (Bern 1994)
; 98(11): 597-602, 2009 May 27.
Article
em De
| MEDLINE
| ID: mdl-19472145
Molecular imaging enables to assess disease-associated processes at the cellular and molecular level. Nuclear medicine techniques are already available in the clinical routine. Besides these techniques, intensive research has been performed in the field of ultrasound. The development of target-specific ultrasound contrast agents in combination with modern imaging systems transformed ultrasound to a capable molecular imaging technique. It has been shown that the expression of disease-associated endothelial receptors can be assessed using targeted microbubbles, demonstrating its high value in the diagnosis of several diseases. The broad availability of suitable ultrasound systems promises a wide utilisation in the clinical routine, once clinically approved contrast agents are available. This review summarizes the basics and the current status of molecular ultrasound imaging.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ultrassonografia
/
Meios de Contraste
/
Microbolhas
/
Biologia Molecular
/
Neoplasias
/
Neovascularização Patológica
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Animals
/
Humans
Idioma:
De
Ano de publicação:
2009
Tipo de documento:
Article